369 related articles for article (PubMed ID: 12430958)
1. The structural basis of pulmonary hypertension in chronic lung disease: remodelling, rarefaction or angiogenesis?
Hopkins N; McLoughlin P
J Anat; 2002 Oct; 201(4):335-48. PubMed ID: 12430958
[TBL] [Abstract][Full Text] [Related]
2. Chronic hypoxia causes angiogenesis in addition to remodelling in the adult rat pulmonary circulation.
Howell K; Preston RJ; McLoughlin P
J Physiol; 2003 Feb; 547(Pt 1):133-45. PubMed ID: 12562951
[TBL] [Abstract][Full Text] [Related]
3. Structural basis of hypoxic pulmonary hypertension: the modifying effect of chronic hypercapnia.
Howell K; Ooi H; Preston R; McLoughlin P
Exp Physiol; 2004 Jan; 89(1):66-72. PubMed ID: 15109211
[TBL] [Abstract][Full Text] [Related]
4. Angiogenesis in chronic lung disease.
Voelkel NF; Douglas IS; Nicolls M
Chest; 2007 Mar; 131(3):874-879. PubMed ID: 17356107
[TBL] [Abstract][Full Text] [Related]
5. The vascular bed in COPD: pulmonary hypertension and pulmonary vascular alterations.
Sakao S; Voelkel NF; Tatsumi K
Eur Respir Rev; 2014 Sep; 23(133):350-5. PubMed ID: 25176971
[TBL] [Abstract][Full Text] [Related]
6. Cellular and molecular mechanisms in the pathogenesis of severe pulmonary hypertension.
Voelkel NF; Tuder RM
Eur Respir J; 1995 Dec; 8(12):2129-38. PubMed ID: 8666110
[TBL] [Abstract][Full Text] [Related]
7. [The effects of hypoxia on initiation and progression of cardiovascular disease in patients with chronic obstructive pulmonary disease].
Lyzogub VH; Savchenko OV; Zaval's'ka TV; Dykukha IS; Tyravs'ka IuV
Lik Sprava; 2012; (5):27-34. PubMed ID: 23534269
[TBL] [Abstract][Full Text] [Related]
8. Chronic hypoxia-induced pulmonary hypertension does/does not lead to loss of pulmonary vasculature.
Berg JT
J Appl Physiol (1985); 2007 Oct; 103(4):1455. PubMed ID: 17916681
[No Abstract] [Full Text] [Related]
9. The pathophysiological basis of chronic hypoxic pulmonary hypertension in the mouse: vasoconstrictor and structural mechanisms contribute equally.
Cahill E; Rowan SC; Sands M; Banahan M; Ryan D; Howell K; McLoughlin P
Exp Physiol; 2012 Jun; 97(6):796-806. PubMed ID: 22366565
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary hypertension in COPD: old and new concepts.
Barberà JA; Peinado VI; Santos S
Monaldi Arch Chest Dis; 2000 Dec; 55(6):445-9. PubMed ID: 11272628
[TBL] [Abstract][Full Text] [Related]
11. Counterpoint: Chronic hypoxia-induced pulmonary hypertension does not lead to loss of pulmonary vasculature.
McLoughlin P; McMurtry I
J Appl Physiol (1985); 2007 Oct; 103(4):1451-3; discussion 1453-4. PubMed ID: 17916678
[No Abstract] [Full Text] [Related]
12. Inhibition of Rho-kinase attenuates hypoxia-induced angiogenesis in the pulmonary circulation.
Hyvelin JM; Howell K; Nichol A; Costello CM; Preston RJ; McLoughlin P
Circ Res; 2005 Jul; 97(2):185-91. PubMed ID: 15961717
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary vascular abnormalities in chronic obstructive pulmonary disease undergoing lung transplant.
Peinado VI; Gómez FP; Barberà JA; Roman A; Angels Montero M; Ramírez J; Roca J; Rodriguez-Roisin R
J Heart Lung Transplant; 2013 Dec; 32(12):1262-9. PubMed ID: 24263025
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary vasculature in COPD: The silent component.
Blanco I; Piccari L; Barberà JA
Respirology; 2016 Aug; 21(6):984-94. PubMed ID: 27028849
[TBL] [Abstract][Full Text] [Related]
15. Chronic airway infection leads to angiogenesis in the pulmonary circulation.
Hopkins N; Cadogan E; Giles S; McLoughlin P
J Appl Physiol (1985); 2001 Aug; 91(2):919-28. PubMed ID: 11457811
[TBL] [Abstract][Full Text] [Related]
16. Point:Counterpoint: Chronic hypoxia-induced pulmonary hypertension does/does not lead to loss of pulmonary vasculature.
Rabinovitch M; Chesler N; Molthen RC
J Appl Physiol (1985); 2007 Oct; 103(4):1449-51. PubMed ID: 17363624
[No Abstract] [Full Text] [Related]
17. Peroxisome proliferator-activated receptor gamma (PPARgamma) expression is decreased in pulmonary hypertension and affects endothelial cell growth.
Ameshima S; Golpon H; Cool CD; Chan D; Vandivier RW; Gardai SJ; Wick M; Nemenoff RA; Geraci MW; Voelkel NF
Circ Res; 2003 May; 92(10):1162-9. PubMed ID: 12714563
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary hypertension in chronic obstructive pulmonary disease: current theories of pathogenesis and their implications for treatment.
Wright JL; Levy RD; Churg A
Thorax; 2005 Jul; 60(7):605-9. PubMed ID: 15994270
[TBL] [Abstract][Full Text] [Related]
19. Pericytes in chronic lung disease.
Rowley JE; Johnson JR
Int Arch Allergy Immunol; 2014; 164(3):178-88. PubMed ID: 25034005
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide and other novel therapies for pulmonary hypertension.
Napoli C; Loscalzo J
J Cardiovasc Pharmacol Ther; 2004 Mar; 9(1):1-8. PubMed ID: 15094962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
